NovaBay Pharmaceuticals

📍 Emeryville, United States🗓 Founded 2000👥 59 employees💰 Last funded Oct 2010
Pharmaceutical Manufacturing🌐 novabay.com
Website LinkedIn
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare, skincare, and wound care products. NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash Solution, is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to eyecare consumers through online distribution channels such as Amazon. DERMAdoctor® offers more than 30 OTC dermatologist-developed skincare products through the DERMAdoctor website, well-known traditional and digital beauty retailers, and international distributors. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne® brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase® brand is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd. NovaBay Pharmaceuticals, Inc. is publicly traded (NYSE: NBY).
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2000
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals has 2 investors on record on gritt.io and 1 late-stage investors.
When did NovaBay Pharmaceuticals last raise funding?
The most recent investment in NovaBay Pharmaceuticals recorded on gritt.io was in October 2010.
When was NovaBay Pharmaceuticals founded?
NovaBay Pharmaceuticals was founded in 2000.
What industry is NovaBay Pharmaceuticals in?
NovaBay Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is NovaBay Pharmaceuticals based?
NovaBay Pharmaceuticals is headquartered in Emeryville, United States.